vimarsana.com

Latest Breaking News On - Quantitative myasthenia gravis - Page 11 : vimarsana.com

Rituximab Reduces Risk for Disease Manifestation in New-Onset Myasthenia Gravis

Rituximab reduces the risk of disease manifestation and the need for rescue treatments in patients with new-onset myasthenia gravis.

Quantitative myasthenia gravisMyasthenia gravis activityDaily lifeMyasthenia gravis quality

Rituximab Studied as Add-On Therapy for New-Onset Myasthenia Gravis

A single infusion of rituximab early after the onset of generalized myasthenia gravis improves outcomes at 16 weeks.

Fredrik piehlKarolinska university hospitalHealthday newsMyasthenia gravis activitiesDaily livingMyasthenia gravis qualityQuantitative myasthenia gravis

COVID-19 mRNA Vaccines Safe in Stable Patients With Myasthenia Gravis

Among stable patients with myasthenia gravis (MG), COVID-19 vaccination is not associated with clinical exacerbation of MG symptoms.

Comunidad autonoma de catalunaQuantitative myasthenia gravis

UCB presents latest data from generalized myasthenia gravis portfolio at AANEM meeting

/PRNewswire/ UCB, a global biopharmaceutical company, announced today it is presenting results from across its portfolio in generalized myasthenia gravis.

Bruxelles capitaleDaphne teoCharl van zylJim baxterIris loew friedrichAntje witteLaurent schotsNeurology head of europe internationalUs communicationsAmerican association of neuromuscular electrodiagnostic medicineBrand communicationsEuropean commissionDrug administrationCorporate communicationsEuropean unionMyasthenia gravis foundation of america

argenx Submits Biologics License Application to U S Food and Drug Administration for Subcutaneous Efgartigimod for Treatment of Generalized Myasthenia Gravis

21.09.2022 - Submission package based on positive data from the Phase 3 ADAPT-SC trial demonstrating noninferiority of subcutaneous (SC) efgartigimod compared to intravenously administered VYVGART (efgartigimod alfa-fcab) based on total immunoglobulin G (IgG) . Seite 1

Tim van hauwermeirenChief executive officerMyasthenia gravis activitiesDaily livingQuantitative myasthenia gravis

vimarsana © 2020. All Rights Reserved.